Thomas C. Hardin - Concepedia

Author

Thomas C. Hardin

The University of Texas Health Science Center at San Antonio

Also Known As

T C Hardin, Thomas C Hardin, Thomas C. Hardin, Thomas Hardin

Publications

753

Citations

H-Index

Concepts

All Affiliations

The University of Texas Health Science Center at San Antonio South Texas Veterans Health Care System The University of Texas at Austin Austin College Murphy Oil Corporation (United States)

About

Thomas C. Hardin is an author at The University of Texas Health Science Center at San Antonio specializing in medicine, pharmacology, and antibiotics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	254
2	Pharmacology	7	7	254
3	Health Sciences	2	2	64
4	Microbiology	2	2	82
5	Pathology	1	1	10

Thomas C. Hardin

Publications

609

Citations

H-Index

Page 1

	Year	Citations
Association of Antibiotic Utilization Measures and Control of Multiple-Drug Resistance in<i>Klebsiella pneumoniae</i> Jan E. Patterson, Thomas C. Hardin, Cindy A. Kelly, Infection Control and Hospital Epidemiology	2000	152
Pharmacokinetics and pharmacodynamics of cefepime administered by intermittent and continuous infusion David S. Burgess, Rhonda W. Hastings, Thomas C. Hardin Clinical Therapeutics Therapeutic Drug MonitoringMedicineCerebrospinal FluidPharmacotherapyPharmacology	2000	73
Hyperlipidemia Associated with Protease Inhibitor Therapy Kelly Echevarria, Thomas C. Hardin, Jean A. Smith Annals of Pharmacotherapy	1999	73
Pharmacodynamics of fluconazole, itraconazole, and amphotericin B against Candida albicans☆ David S. Burgess, Rhonda W. Hastings, Kimberly K. Summers, Diagnostic Microbiology and Infectious Disease Antifungal AgentAntibioticsMedicineAntifungal AgentsAmphotericin B	2000	57
A Prospective Double-Blind Trial of Intracorporeal Papaverine Versus Prostaglandin E1 in the Treatment of Impotence Michael F. Sarosdy, Clayton H. Hudnall, Deborah Erickson, The Journal of Urology	1989	46
Biological Effects of Cocaine Derivatives I: Improved Synthesis and Pharmacological Evaluation of Norcocaine Ronald F. Borne, John A. Bedford, Judith L. Buelke, Journal of Pharmaceutical Sciences Psychoactive DrugBiological EffectsPharmacological StudyAddictionMedicine	1977	44
Postburn Serum Drug Binding and Serum Protein Concentrations Duane C. Bloedow, John F. Hansbrough, Thomas C. Hardin, The Journal of Clinical Pharmacology	1986	33
Pharmacokinetics and pharmacodynamics of aztreonam administered by continuous intravenous infusion David S. Burgess, Kimberly K. Summers, Thomas C. Hardin Clinical Therapeutics Therapeutic Drug MonitoringContinuous Intravenous InfusionPharmacological StudyPharmacologyClinical Pharmacology	1999	25
In vitro evaluation of the activity of two doses of Levofloxacin alone and in combination with other agents against Pseudomonas aeruginosa David S. Burgess, Ronald G. Hall, Thomas C. Hardin Diagnostic Microbiology and Infectious Disease Antibacterial AgentsAnti-infective AgentsAntimicrobial SusceptibilityAntibioticsMedicine	2003	25
Telavancin Hospital-Acquired Pneumonia Trials: Impact of Gram-Negative Infections and Inadequate Gram-Negative Coverage on Clinical Efficacy and All-Cause Mortality Melinda K. Lacy, Martín E. Stryjewski, Whedy Wang, Clinical Infectious Diseases	2015	23

Page 1